Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lycopene Supplementation in BPH
NCT00154843Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Mar 2004
- Primary completion
- Jun 2005
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of lycopene in benign prostatic hyperplasia (BPH) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Serum lycopene levels. Started Mar 2004; status: completed.
02
Drugs
lycopene
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00154843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154843.